PMID
Data
Article Title
Organization
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof

Dana-Farber Cancer Institute
Cyclic molecules as Bruton's tyrosine kinase inhibitor

Minghui Pharmaceutical (Shanghai)
ANTAGONIST OF ADENOSINE RECEPTORS

Adorx Therapeutics
COMPOUND FOR EGFR KINASE INHIBITOR, COMPOSITION, AND USE THEREOF

Zhejiang University
Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) Inhibitors

Department Of Health and Human Services
Weed control methods and related compositions and plants

Syngenta Crop Protection
RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN

Tufts College
N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV 1.7 AND/OR NAV 1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME AND KITS

Eurofarma
FUSED TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE

Jiangsu Hengrui Pharmaceuticals
Methods for treating neurological symptoms associated with lysosomal storage diseases

Genzyme
PYRIMIDINE OR PYRIDINE DERIVATIVES USEFUL AS HCN2 MODULATORS

King''s College London
Pyridine derivatives with c-linked cyclic substituents as cGAS inhibitors

Boehringer Ingelheim International
SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT

Merck Sharp & Dohme
4'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USE

Gilead Sciences
Methods and Compositions for Treating Cancer

Ohio Northern University
NUCLEOSIDE ANALOG AND USE THEREOF

Shanghai Institute of Materia Medica
1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES

Newave Pharmaceutical
Dizocilpine derivatives as peripheral NMDA receptor antagonists

Institut National De La Sante Et De La Recherche Medicale (Inserm
NOVEL TETRAZOLES

Boehringer Ingelheim International
Heterocycle RMB39 Modulators

Recursion Pharmaceuticals
BENZOPYRAZOLE INHIBITORS OF SARM1

Disarm Therapeutics
Furin inhibitors

Glaxosmithkline Intellectual Property Development
Isoquinoline-steroid conjugates and uses thereof

Aerie Pharmaceuticals
Pyridinone MK2 inhibitors and uses thereof

Xinthera
Polycyclic compounds as allosteric SHP2 inhibitors

Revolution Medicines
Oxadiazaspiro compounds for the treatment of drug abuse and addiction

Esteve Pharmaceuticals
Cyanoaryl-aniline compounds for treatment of dermal disorders

Nflection Therapeutics
Bicyclic heterocycles as FGFR inhibitors

Incyte
2-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4′-bipyridin]-2′-yl)-7,7-dimethyl-7,8-dihydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one as a BTK inhibitor

Hutchison Medipharma
6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors

Novartis
Imidazolidin-2-one compounds as PRMT5 modulators

Aurigene Discovery Technologies
Treatment of GVHD

Kadmon
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same

Hanmi Pharm.
Macrocyclic compounds that inhibit MCL-1 protein

Amgen
PCSK9 inhibitors and methods of use thereof

Astrazeneca
Triazolopyrimidine compounds and uses thereof

Novartis
Dynamin-1-like protein inhibitors

Mitobridge
Sting agonists

Venenum Biodesign
Inhibitors of NEK7 kinase

Halia Therapeutics
Fused pyrazine derivatives as A2A / A2B inhibitors

Incyte
Selective estrogen receptor degraders

Eli Lilly
Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof

Chia Tai Tianqing Pharmaceutical Group
Bicyclic ketone compounds and methods of use thereof

Genentech
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies

Bayer Pharma Aktiengesellschaft
Heterocyclic compounds and uses thereof

Infinity Pharmaceuticals
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

Valo Early Discovery
Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitors

H. Lundbeck
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Array Biopharma
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same

Hanmi Pharm.
Pet imaging agents

Novartis
Inhibitors of lysine specific demethylase-1

Celgene Quanticel Research
Modulators of the 5-hydroxytryptamine receptor 7 and their method of use

Temple University
5-HT2C receptor agonists and compositions and methods of use

Arena Pharmaceuticals
Processes for preparing ATR inhibitors

Vertex Pharmaceuticals
Bicyclic inhibitors of histone deacetylase

Rodin Therapeutics
Alkynyl dihydroquinoline sulfonamide compounds

Amgen
STK4 inhibitors for treatment of hematologic malignancies

Dana-Farber Cancer Institute
Pyrrolidine derivatives

Hoffmann-La Roche
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including same

Crystalgenomics
Ingenol analogs, pharmaceutical compositions and methods of use thereof

Glaxosmithkline Intellectual Property Development
Glycosidase inhibitors

Asceneuron
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine and cosmetics

Galderma Research & Development
Quinolone derivatives as FGFR inhibitors

Principia Biopharma
PARG inhibitory compounds

Cancer Research Technology
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

Bristol-Myers Squibb
Oxazole orexin receptor antagonists

Merck Sharp & Dohme
Macrocyclic immunomodulators

Chemocentryx
Biaryl kinase inhibitors

Bristol-Myers Squibb
Bicyclic heterocycles as FGFR4 inhibitors

Incyte
Materials and method for inhibiting replication protein A and uses thereof

Indiana University Research and Technology
Pyridine derivatives

Hoffmann-La Roche
Benzazepine dicarboxamide compounds

Hoffmann-La Roche
Pyrimidine FGFR4 inhibitors

Eisai R&D Management
Pyrimidodiazepinone compound

Kyowa Hakko Kirin
Inhibitors of c-fms kinase

Janssen Pharmaceutica
C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use

Merck Sharp & Dohme
Substituted pyridinone-pyridinyl compounds

Confluence Life Sciences
Aroyl thiourea derivatives

University Court of The University of St Andrews
Synthesis and biological evaluation of polyhydroxy benzophenone as mushroom tyrosinase inhibitors.

Sun Yat-Sen University
Green synthesis, inhibition studies of yeast a-glucosidase and molecular docking of pyrazolylpyridazine amines.

University of The Punjab
Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitors

Bayer Intellectual Property
Heteroaryl alkyne compound and use thereof

Nanjing Sanhome Pharmaceutical
IRE-1α inhibitors

Mannkind
2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.

Kurukshetra University
Curcumin analogues as zinc chelators and their uses

The Research Foundation of State University of New York
Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.

University of Siena
Inhibitors of phosphodiesterase 11 (PDE11)

Boston College
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators

Actelion Pharmaceuticals
Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase

Janssen Pharmaceutica
Chrysophaentin analogs that inhibit FtsZ protein

The United States of America, As Represented By The Secretary, Department of Health and Human Services
Triazine derivative and pharmaceutical composition comprising the same

Shionogi
Indole or indazole derivative or salt thereof

Taiho Pharmaceutical
Compounds for the treatment of neurodegenerative diseases

Proteotech
Inhibitor Fingerprinting of Rhomboid Proteases by Activity-Based Protein Profiling Reveals Inhibitor Selectivity and Rhomboid Autoprocessing.

Technische Universität München
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases

Merck Sharp & Dohme
Substituted fused imidazoles and pyrazoles and use thereof

Bayer Intellectual Property
Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.

University of Illinois At Chicago
Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.

China Pharmaceutical University
Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.

University of Western Ontario
Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of a-glucosidase.

Hazara University
Synthesis of benzimidazole derivatives as potent ß-glucuronidase inhibitors.

Universiti Teknologi Mara (Uitm)
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases

Bristol-Myers Squibb
Compound of a reverse-turn mimetic and a production method and use therefor

Jw Pharmaceutical
Pyridopyrazine derivatives and their use

Zentaris
Quinolinyl glucagon receptor modulators

Pfizer
Selective glycosidase inhibitors and uses thereof

TBA
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds

Pfizer
N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

Abbvie
Substituted imidazopyridinyl compounds

Arqule
Azetidine and piperidine compounds useful as PDE10 inhibitors

Amgen
Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity

Shionogi
Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereof

Albany Molecular Research
Aminodihydrothiazine derivatives

Shionogi
KAT II inhibitors

Pfizer
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1

Vitae Pharmaceuticals
Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use

Merck Sharp & Dohme
Conformationally restricted urea inhibitors of soluble epoxide hydrolase

University of California
Evaluation of 5-enolpyruvoylshikimate-3-phosphate synthase substrate and inhibitor binding by stopped-flow and equilibrium fluorescence measurements.

Monsanto Agricultural
Inhibitors

Probiodrug
Histone deacetylase inhibitors

Orchid Chemicals & Pharmaceuticals
Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the Staphylococcus aureus FabI Enzyme-Product Complex.

Stony Brook University
Rational design of quinazoline-based irreversible inhibitors of human erythrocyte purine nucleoside phosphorylase.

Arizona State University
Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L.

Epizyme
Synthesis and inhibitory activity of ureidophosphonates, against acetylcholinesterase: pharmacological assay and molecular modeling.

Institute For Advanced Studies In Basic Sciences (Iasbs)
Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.

Duquesne University
The rabbit motilin receptor: molecular characterisation and pharmacology.

Glaxosmithkline
In vitro inhibition of cytosolic carbonic anhydrases I and II by some new dihydroxycoumarin compounds.

Balikesir University Science & Art Faculty
Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors.

Shinshu University
AF2 interaction with Ascaris suum body wall muscle membranes involves G-protein activation.

Pharmacia
Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.

Bayer
Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.

Novartis Pharma
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

Nih
Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans.

Hungarian Academy of Sciences
Yeast hexokinase inhibitors designed from the 3-D enzyme structure rebuilding.

Universite Paul Sabatier
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.

University of North Carolina
Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.

King'S College London
Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.

Synaptic Pharmaceutical
Design and Synthesis of Potent Inhibitors of Glutamine Synthetase

Chevron Chemical
Heteroarylimino-4-thiazolidinones as inhibitors of cartilage degradation.

University of Catania
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.

Eberhard Karls University of Tuebingen
In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist.

Hoechst Marion Roussel
Characterization of cloned somatostatin receptors SSTR4 and SSTR5.

University of Pennsylvania
SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.

Sanofi Recherche
Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity.

Merz
Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites.

Stanford University
The characterization of [3H]sulpiride binding sites in rat striatal membranes.

St, Marianna University School of Medicine
Characterization of the binding of a morphine (mu) receptor-specific ligand: Tyr-Pro-NMePhe-D-Pro-NH2, [3H]-PL17.

Burroughs Wellcome
McN-5652: a highly potent inhibitor of serotonin uptake.

Mcneil Pharmaceutical
Molecular cloning and expression of a dopamine D2 receptor from human retina.

National Institute of Neurological Disorders and Stroke
NMDA receptor agonists derived from ibotenic acid. Preparation, neuroexcitation and neurotoxicity.

Royal Danish School of Pharmacy
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.

University of Toronto
Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.

University of Texas
Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta.

Synaptic Pharmaceutical
Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.

Synaptic Pharmaceutical
Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.

UniversitÉ
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.

Ariad Pharmaceuticals
Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine.

TBA
Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase.

University of Connecticut
Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli.

University of Tokyo
Covalent reactions of wortmannin under physiological conditions.

Massachusetts General Hospital